| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/ONC.2009.151 |
| P698 | PubMed publication ID | 19503094 |
| P2093 | author name string | J Yanagisawa | |
| Y Nakajima | |||
| K Kimura | |||
| S Kawasaki | |||
| A Murayama | |||
| I Ito | |||
| K Akaogi | |||
| S-h Oie | |||
| P2860 | cites work | Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest | Q24311735 |
| Epigenetic control of rDNA loci in response to intracellular energy status | Q24313528 | ||
| A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells | Q24322959 | ||
| Transcriptional profiling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation | Q24648756 | ||
| The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter | Q24653488 | ||
| Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage | Q24655032 | ||
| The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| A signature motif in transcriptional co-activators mediates binding to nuclear receptors | Q27860938 | ||
| Klf4 is a transcription factor required for establishing the barrier function of the skin | Q28115084 | ||
| Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer | Q28155828 | ||
| Combinatorial control of gene expression by nuclear receptors and coregulators | Q28209095 | ||
| Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling | Q28213257 | ||
| X chromosomal abnormalities in basal-like human breast cancer | Q28296876 | ||
| Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis | Q28592219 | ||
| Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells | Q28592799 | ||
| Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition | Q28593494 | ||
| Genes that mediate breast cancer metastasis to lung | Q29547479 | ||
| The human estrogen receptor has two independent nonacidic transcriptional activation functions | Q29617089 | ||
| Stromal gene expression predicts clinical outcome in breast cancer | Q33330931 | ||
| Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif | Q33617171 | ||
| An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival | Q33939753 | ||
| Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage | Q34092984 | ||
| Down-regulation of gut-enriched Kruppel-like factor expression in esophageal cancer | Q34159812 | ||
| Ectopic expression of Kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier | Q34195392 | ||
| The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene | Q34462232 | ||
| Activation of the human pregnancy-specific glycoprotein PSG-5 promoter by KLF4 and Sp1. | Q34505246 | ||
| Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells | Q37158208 | ||
| Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray | Q38347517 | ||
| Turning off estrogen receptor beta-mediated transcription requires estrogen-dependent receptor proteolysis. | Q39125264 | ||
| The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer | Q39626911 | ||
| Characterization of the structure and regulation of the murine gene encoding gut-enriched Krüppel-like factor (Krüppel-like factor 4). | Q39729656 | ||
| SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta | Q39979150 | ||
| Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene | Q40169562 | ||
| Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function | Q40318351 | ||
| Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer | Q40564116 | ||
| Estradiol stabilizes p53 protein in breast cancer cell line, MCF-7. | Q40652110 | ||
| Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway | Q40696363 | ||
| Role of gut-enriched Krüppel-like factor in colonic cell growth and differentiation | Q40852596 | ||
| Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk | Q40862149 | ||
| Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo | Q44043409 | ||
| p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage | Q47735165 | ||
| Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. | Q51929705 | ||
| The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways | Q73821163 | ||
| p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells | Q77138780 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2894-2902 | |
| P577 | publication date | 2009-06-08 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha | |
| P478 | volume | 28 |
| Q38980243 | A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers |
| Q40090503 | A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays |
| Q36347241 | A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation |
| Q36210886 | AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer |
| Q90293669 | Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer |
| Q34154752 | Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway |
| Q26752312 | Cancer Stem Cell Hierarchy in Glioblastoma Multiforme |
| Q34243311 | Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition |
| Q33857846 | Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia |
| Q51062285 | Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells. |
| Q34066627 | Doxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells |
| Q34116124 | ERK5/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning |
| Q37711321 | Estrogens, regulation of p53 and breast cancer risk: a balancing act. |
| Q33829480 | Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance. |
| Q36756450 | Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland |
| Q37609227 | FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer |
| Q34194768 | Integrative eQTL-based analyses reveal the biology of breast cancer risk loci |
| Q38786245 | KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis |
| Q52764536 | KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas. |
| Q90643036 | KLF4 overexpression decreases the viability, invasion and migration of papillary thyroid cancer cells |
| Q37564503 | KLF4α stimulates breast cancer cell proliferation by acting as a KLF4 antagonist. |
| Q34603384 | Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). |
| Q33883339 | Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression |
| Q38717810 | Kruppel-like factor 4 inhibits non-small cell lung cancer cell growth and aggressiveness by stimulating transforming growth factor-β1-meidated ERK/JNK/NF-κB signaling pathways |
| Q39263949 | Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation. |
| Q39151066 | Krüppel-like factor 4 (KLF4): What we currently know |
| Q34469953 | Krüppel-like factor 4 induces apoptosis and inhibits tumorigenic progression in SK-BR-3 breast cancer cells |
| Q35095237 | Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. |
| Q52602513 | Krüppel-like factor 4 promotes c-Met amplification-mediated gefitinib resistance in non-small-cell lung cancer. |
| Q37761837 | Krüppel-like factors 4 and 5: unity in diversity |
| Q35116300 | Krüppel-like factors are effectors of nuclear receptor signaling |
| Q38141516 | Krüppel-like factors in cancer |
| Q38178811 | Krüppel-like factors in cancer progression: three fingers on the steering wheel |
| Q92278497 | Long non-coding RNA LINC00673 silencing inhibits proliferation and drug resistance of prostate cancer cells via decreasing KLF4 promoter methylation |
| Q37189474 | Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer. |
| Q34754561 | MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells |
| Q24612560 | Mammalian Krüppel-Like Factors in Health and Diseases |
| Q39225627 | Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells |
| Q34534676 | N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth |
| Q39006292 | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study |
| Q35177151 | Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer |
| Q33591335 | Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer |
| Q89832073 | Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance |
| Q44902948 | Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations |
| Q30419271 | Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling |
| Q37577062 | The miR-7 identified from collagen biomaterial-based three-dimensional cultured cells regulates neural stem cell differentiation |
| Q26785448 | The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer |
| Q55314501 | The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. |
| Q37417687 | Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases |
| Q34305387 | Uncoupled embryonic and extra-embryonic tissues compromise blastocyst development after somatic cell nuclear transfer. |
| Q38999422 | Upregulation of KLF4 by methylseleninic acid in human esophageal squamous cell carcinoma cells: Modification of histone H3 acetylation through HAT/HDAC interplay |
| Q35666432 | c-Myc plays a key role in TADs-induced apoptosis and cell cycle arrest in human hepatocellular carcinoma cells. |
| Q84310394 | p53 Binds to estrogen receptor 1 promoter in human breast cancer cells |
Search more.